A LOOK AT THE NEW PATENT REFORM LEGISLATION. I haven’t been following it closely enough to have an opinion, really. I note, though, that positions seem to break down by industry, with IT people generally not liking strong patents while pharma people do. That makes sense, given their different business models. I suppose that actually treating different kinds of patents differently is unworkable.